Patent ID: 9672329
Date: 2017-06-06
CPC Classifications: B01L,C12Q,G01N,G16B,G16H

Claim:
1. An assay system comprising: an analysis region comprising one or more binding partners immobilized to a solid phase portion therein, wherein the one or more binding partners are selected from a group consisting of binding partners that bind total prostate-specific antigen (tPSA), binding partners that bind free prostate-specific antigen (fPSA), binding partners that bind intact prostate-specific antigen (iPSA) and binding partners that bind human kallikrein 2 (hK2); a detection device, the detection device being configured to detect a presence of an analyte in a sample from the analysis region, wherein the analyte is selected from a group consisting of tPSA, fPSA, iPSA, and hK2; and a computer programmed to: